• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度和中度阿尔茨海默病患者大型随机临床试验中依赖量表的心理测量特性。

Psychometric properties of the Dependence Scale in large randomized clinical trials of patients with mild and moderate Alzheimer's disease.

作者信息

Wyrwich Kathleen W, Auguste Priscilla, Buchanan Jacqui, Rudell Katja, Lacey Loretto, Leibman Christopher, Symonds Tara, Brashear H Robert

机构信息

Evidera (formerly United BioSource Corporation), Bethesda, MD, USA

Evidera (formerly United BioSource Corporation), Bethesda, MD, USA.

出版信息

Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):620-9. doi: 10.1177/1533317514527336. Epub 2014 Apr 15.

DOI:10.1177/1533317514527336
PMID:24736801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10852768/
Abstract

OBJECTIVE

The need for assistance from others is a hallmark concern in Alzheimer's disease (AD). The psychometric properties of the Dependence Scale (DS) for measuring treatment benefit were investigated in large randomized clinical trials of patients with mild to moderate AD.

METHODS

Reliability, validity, and responsiveness of the DS were examined. Path models appraised relationships and distinctiveness of key AD measures. The responder definition was empirically derived.

RESULTS

Generally acceptable reliability (α ≥ .65), significant (P < .001) known-groups tests, and moderate to strong correlations (r ≥ .31) confirmed the DS psychometric properties. Path models supported relationships and distinctiveness of key AD measures. A DS change of ≤ 1 point for patients with limited home care and ≤ 2 points for patients with assisted living care best described stability of the level of dependence on caregivers.

CONCLUSION

The DS is a psychometrically robust measure in mild to moderate AD. The empirically derived responder definition aids in the interpretation of DS change.

摘要

目的

对他人帮助的需求是阿尔茨海默病(AD)的一个标志性问题。在轻度至中度AD患者的大型随机临床试验中,对用于衡量治疗益处的依赖量表(DS)的心理测量特性进行了研究。

方法

检查了DS的信度、效度和反应性。路径模型评估了关键AD测量指标之间的关系和独特性。反应者定义是通过实证得出的。

结果

总体可接受的信度(α≥0.65)、显著的(P<0.001)已知组检验以及中度至强的相关性(r≥0.31)证实了DS的心理测量特性。路径模型支持关键AD测量指标之间的关系和独特性。对于家庭护理有限的患者,DS变化≤1分,对于辅助生活护理的患者,DS变化≤2分,最能描述对照顾者依赖程度的稳定性。

结论

DS在轻度至中度AD中是一种心理测量稳健的测量方法。通过实证得出的反应者定义有助于对DS变化的解释。

相似文献

1
Psychometric properties of the Dependence Scale in large randomized clinical trials of patients with mild and moderate Alzheimer's disease.轻度和中度阿尔茨海默病患者大型随机临床试验中依赖量表的心理测量特性。
Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):620-9. doi: 10.1177/1533317514527336. Epub 2014 Apr 15.
2
Reliability, validity, and interpretation of the dependence scale in mild to moderately severe Alzheimer's disease.轻度至中度阿尔茨海默病依赖性量表的信度、效度及解读。
Am J Alzheimers Dis Other Demen. 2013 Dec;28(8):738-49. doi: 10.1177/1533317513504609.
3
Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed.轻度至中度阿尔茨海默病患者大型临床试验样本中的生活质量与效用测量:观察到的决定因素及变化水平
Value Health. 2015 Jul;18(5):638-45. doi: 10.1016/j.jval.2015.03.1787. Epub 2015 Apr 10.
4
Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.ADAS-Cog 和 NTB 量表用于测量药物反应的心理计量学评估。
Acta Neurol Scand. 2014 Feb;129(2):114-22. doi: 10.1111/ane.12153. Epub 2013 Jun 13.
5
The Empirical Behavioral Pathology in Alzheimer's Disease (E-BEHAVE-AD) Rating Scale.阿尔茨海默病经验性行为病理学(E-BEHAVE-AD)评定量表
Int Psychogeriatr. 1996 Summer;8(2):247-66. doi: 10.1017/s1041610296002621.
6
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.三期 solanezumab 试验:轻度阿尔茨海默病患者的次要结局。
Alzheimers Dement. 2016 Feb;12(2):110-120. doi: 10.1016/j.jalz.2015.06.1893. Epub 2015 Aug 1.
7
The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease.阿尔茨海默病评估量表:轻至中度阿尔茨海默病多中心临床试验中的心理测量特性评估及认知衰退模式
Alzheimer Dis Assoc Disord. 2001 Oct-Dec;15(4):174-83. doi: 10.1097/00002093-200110000-00003.
8
Impact of Alzheimer's Disease on Caregiver Questionnaire: internal consistency, convergent validity, and test-retest reliability of a new measure for assessing caregiver burden.阿尔茨海默病对照顾者问卷的影响:一种评估照顾者负担的新测量方法的内部一致性、收敛效度和重测信度
Health Qual Life Outcomes. 2014 Sep 4;12:114. doi: 10.1186/s12955-014-0114-3.
9
Dependence scale for Alzheimer's disease: relationship with other clinical indicators and psychometric properties.阿尔茨海默病依赖量表:与其他临床指标的关系及心理测量特性
J Geriatr Psychiatry Neurol. 2015 Jun;28(2):117-25. doi: 10.1177/0891988714554711. Epub 2014 Oct 20.
10
Cognitive Performance Test: a new approach to functional assessment in Alzheimer's disease.认知功能测试:阿尔茨海默病功能评估的一种新方法。
J Geriatr Psychiatry Neurol. 1994 Jan-Mar;7(1):46-54.

引用本文的文献

1
Dependence Clusters in Alzheimer Disease and Medicare Expenditures: A Longitudinal Analysis From the Predictors Study.阿尔茨海默病中的依赖簇与医疗保险支出:来自预测因子研究的纵向分析。
Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):293-298. doi: 10.1097/WAD.0000000000000402.
2
Utility of the Dependence Scale in dementia: validity, meaningfulness, and health economic considerations.依赖量表在痴呆症中的效用:有效性、有意义性和健康经济学考虑。
Alzheimers Res Ther. 2018 Aug 13;10(1):78. doi: 10.1186/s13195-018-0414-7.
3
Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease.阿尔茨海默病患者的依赖阶段与药物经济学结果
Alzheimer Dis Assoc Disord. 2017 Jul-Sep;31(3):209-217. doi: 10.1097/WAD.0000000000000198.
4
A Path Analysis of Dependence and Quality of Life in Alzheimer's Disease.阿尔茨海默病中依赖与生活质量的路径分析
Am J Alzheimers Dis Other Demen. 2017 Mar;32(2):108-115. doi: 10.1177/1533317516688297. Epub 2017 Jan 22.

本文引用的文献

1
Reliability, validity, and interpretation of the dependence scale in mild to moderately severe Alzheimer's disease.轻度至中度阿尔茨海默病依赖性量表的信度、效度及解读。
Am J Alzheimers Dis Other Demen. 2013 Dec;28(8):738-49. doi: 10.1177/1533317513504609.
2
Dependence and caregiver burden in Alzheimer's disease and mild cognitive impairment.阿尔茨海默病和轻度认知障碍的依赖和照顾者负担。
Am J Alzheimers Dis Other Demen. 2011 Mar;26(2):110-4. doi: 10.1177/1533317510394649. Epub 2011 Jan 13.
3
Dependence as a unifying construct in defining Alzheimer's disease severity.将依赖作为定义阿尔茨海默病严重程度的统一结构。
Alzheimers Dement. 2010 Nov;6(6):482-93. doi: 10.1016/j.jalz.2009.09.004.
4
Assessment of potential measures in models of progression in Alzheimer disease.阿尔茨海默病进展模型中潜在措施的评估。
Neurology. 2010 Oct 5;75(14):1256-62. doi: 10.1212/WNL.0b013e3181f6133d.
5
A qualitative assessment of the concept of dependence in Alzheimer's disease.阿尔茨海默病中依赖概念的定性评估。
Am J Alzheimers Dis Other Demen. 2010 May;25(3):239-47. doi: 10.1177/1533317509356690. Epub 2010 Feb 10.
6
Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.接受AN1792免疫接种患者的长期随访:抗体应答者功能衰退减缓
Curr Alzheimer Res. 2009 Apr;6(2):144-51. doi: 10.2174/156720509787602852.
7
Bridging from clinical endpoints to estimates of treatment value for external decision makers.从临床终点到为外部决策者评估治疗价值的桥梁搭建。
J Nutr Health Aging. 2009 Mar;13(3):256-9. doi: 10.1007/s12603-009-0068-z.
8
Patient dependence and longitudinal changes in costs of care in Alzheimer's disease.阿尔茨海默病患者的依赖性及护理成本的纵向变化
Dement Geriatr Cogn Disord. 2008;26(5):416-23. doi: 10.1159/000164797. Epub 2008 Oct 22.
9
The relation of patient dependence to home health aide use in Alzheimer's disease.阿尔茨海默病患者的依赖程度与家庭健康护理员使用情况的关系。
J Gerontol A Biol Sci Med Sci. 2008 Sep;63(9):1005-9. doi: 10.1093/gerona/63.9.1005.
10
The effects of patient function and dependence on costs of care in Alzheimer's disease.阿尔茨海默病患者功能及依赖程度对护理成本的影响。
J Am Geriatr Soc. 2008 Aug;56(8):1497-503. doi: 10.1111/j.1532-5415.2008.01798.x. Epub 2008 Jul 24.